Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,785 | -8,819 | -3,984 | -14,194 | -9,980 |
| Depreciation Amortization | 17 | 11 | 6 | 4 | 3 |
| Accounts payable and accrued liabilities | 500 | 765 | 230 | -288 | 156 |
| Other Working Capital | -161 | 983 | 498 | -570 | -294 |
| Other Operating Activity | 432 | -186 | 23 | 953 | 227 |
| Operating Cash Flow | $-11,997 | $-7,247 | $-3,227 | $-14,095 | $-9,889 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -85 | -15 | -10 | -63 | -3 |
| Net Acquisitions | N/A | N/A | N/A | 1,030 | 1,030 |
| Investing Cash Flow | $-85 | $-15 | $-10 | $967 | $1,028 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 5,500 | 5,500 |
| Common Stock Issued | 42,623 | -39 | -39 | 21,507 | 10,000 |
| Other Financing Activity | 0 | 0 | 0 | -69 | -69 |
| Financing Cash Flow | $42,623 | $-39 | $-39 | $26,938 | $15,432 |
| Beginning Cash Position | 15,644 | 15,644 | 15,644 | 1,834 | 1,834 |
| End Cash Position | 46,185 | 8,344 | 12,369 | 15,644 | 8,404 |
| Net Cash Flow | $30,541 | $-7,301 | $-3,276 | $13,810 | $6,570 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,997 | -7,247 | -3,227 | -14,095 | -9,889 |
| Capital Expenditure | -85 | -15 | -10 | -63 | -3 |
| Free Cash Flow | -12,082 | -7,262 | -3,237 | -14,158 | -9,891 |